LEGN
Legend Biotech Corporation
LEGN lost money over the past year, so it has no meaningful PE right now. Analysts expect earnings to recover and profitability to improve, though they disagree widely on how much.
LEGN Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Stable | |
| Weak | |
| Unavailable |
LEGN's revenue is currently healthy, and its profitability is stable, but its cash flow is weak. There isn't enough data to rate its balance sheet.
LEGN PE Valuation
LEGN has no meaningful PE right now: it lost money over the past year.
LEGN Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect strong earnings and revenue growth for LEGN, with profitability improving. However, they disagree widely on these estimates.
LEGN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$0.40 | +$0.82 |
| Q1 2026 | -$0.92 | +$0.06 |
| Q4 2025 | -$0.89 | -$0.02 |
| Q3 2025 | -$0.65 | +$1.09 |
| Q2 2025 | -$1.22 | +$0.18 |
| Q1 2025 | -$0.98 | +$1.46 |
| Q4 2024 | -$0.87 | +$2.09 |
| Q3 2024 | -$1.74 | +$1.27 |
LEGN is still losing money, but far less than before: $0.40 per share over the past year, against $3.32 at its worst in early 2023.
LEGN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $387.5M | +52% |
| Q1 2026 | $305.1M | +56% |
| Q4 2025 | $306.4M | +64% |
| Q3 2025 | $272.3M | +70% |
| Q2 2025 | $255.1M | +37% |
| Q1 2025 | $195.1M | +108% |
| Q4 2024 | $186.5M | +135% |
| Q3 2024 | $160.2M | +67% |
LEGN's revenue has grown year over year for 13 quarters in a row: $388M last quarter, up 52% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 15% | +64 points |
| Q1 2026 | -16% | +35 points |
| Q4 2025 | -6.7% | -28 points |
| Q3 2025 | -16% | +28 points |
| Q2 2025 | -49% | -26 points |
| Q1 2025 | -51% | +13 points |
| Q4 2024 | 22% | +173 points |
| Q3 2024 | -44% | +53 points |
LEGN's operating margin was 15% last quarter, up 64 points from the same quarter a year ago, near the top of its range since 2019.
LEGN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$41.5M | -$19.2M |
| Q1 2026 | -$111.3M | -$5.6M |
| Q4 2025 | -$126.6M | -$42.1M |
| Q3 2025 | $23.8M | +$101.7M |
| Q2 2025 | -$22.3M | -$17.2M |
| Q1 2025 | -$105.8M | -1240% |
| Q4 2024 | -$84.5M | +$18M |
| Q3 2024 | -$77.9M | -$11.6M |
LEGN has burned cash in almost every quarter: −$256M over the past year, against −$290M the year before.
LEGN Net Leverage
LEGN's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
LEGN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 43.8 | Neutral |
| Stochastic | 63.0 | Neutral |
LEGN's weekly RSI is 44 (neutral) and its Stochastic is 63 (neutral).
LEGN PE vs Healthcare Sector
LEGN has no meaningful PE right now: it lost money over the past year.
LEGN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $19.7 | 5.9% below |
| 20 week MA | $20.9 | 11% below |
| 50 week MA | $22.1 | 16% below |
| 100 week MA | $28.2 | 34% below |
| 200 week MA | $42.3 | 56% below |
LEGN is in a downtrend: it's below all five of its weekly moving averages, and 56% below its 200-week average.
LEGN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $37.0 | $29.5 | -20% |
| 2021 | $29.5 | $48.7 | +65% |
| 2022 | $48.7 | $49.8 | +2.3% |
| 2023 | $49.8 | $60.2 | +21% |
| 2024 | $60.2 | $32.5 | -46% |
| 2025 | $32.5 | $22.5 | -31% |
| 2026 YTD | $22.5 | $18.5 | -18% |
LEGN has finished lower in three of the last six years. It's down 18% so far in 2026.